09:54:47 EDT Wed 05 Aug 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Aurora Cannabis Inc
Symbol ACB
Shares Issued 452,733,103
Close 2018-01-04 C$ 13.04
Recent Sedar Documents

Aurora Cannabis adds 91,800 shares of CanniMed

2018-01-04 17:16 ET - News Release

Mr. Terry Booth reports

AURORA PURCHASES 91,800 SHARES OF CANNIMED THERAPEUTICS INC.

Aurora Cannabis Inc. has purchased 91,800 common shares of CanniMed Therapeutics Inc.

The purchases were made in connection with Aurora's previously announced offer to purchase all of the common shares of CanniMed. Aurora announced its intention to purchase common shares of CanniMed in its offer to purchase and takeover bid circular dated Nov. 24, 2017, which is filed on SEDAR under CanniMed's SEDAR profile. CanniMed implemented a shareholder rights plan on Nov. 28, 2017, which prevented Aurora from commencing purchases in a timely fashion. The Ontario Securities Commission and the Saskatchewan Financial and Consumer Affairs Authority, in joint decisions dated Dec. 22, 2017, and issued on Dec. 27, 2017, cease-traded the CanniMed rights plan.

The purchases were made by Aurora in the normal course through the facilities of the Toronto Stock Exchange.

Name of the purchaser:

Aurora Cannabis

Number of CanniMed shares purchased on Jan. 4, 2018:

91,800

Highest price paid for the CanniMed shares on Jan. 4, 2018:

$23.99

Aggregate number of CanniMed shares purchased through a published market since the commencement of the offer:

657,800

Average price paid for the CanniMed shares purchased through a published market since the commencement of the offer:

$22.9817

Total number of CanniMed shares held by Aurora after the purchase:

657,800

How to tender:

Aurora encourages CanniMed shareholders to read the full details of the offer set forth in the takeover bid circular and accompanying offer documents, which contain detailed instructions on how CanniMed shareholders can tender their CanniMed common shares to the offer. For assistance in depositing CanniMed common shares to the offer, CanniMed shareholders should contact the depositary and the information agent for the offer, Laurel Hill Advisory Group at phone: 1-877-452-7184 (North American toll-free) and 1-416-304-0211 (outside North America); facsimile: 416-646-2415; and e-mail: assistance@laurelhill.com.

About the offer

On Nov. 24, 2017, Aurora formally commenced its offer to purchase all of the issued and outstanding common shares of CanniMed for consideration consisting of common shares of Aurora. The offer document, including the takeover bid circular and related documents, are available on SEDAR.

The offer documents are also available on Aurora's website. There is also a website dedicated to the takeover.

Stock options issued

The company granted 300,000 stock options to an officer of the company exercisable at $9.60 per common share. The options shall vest quarterly over a period of 36 months and expire five years from the date of grant.

About Aurora Cannabis Inc.

Aurora's wholly owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations. The company operates a 55,200-square-foot, state-of-the-art production facility in Mountain View county, Alberta, known as Aurora Mountain, a second 40,000-square-foot high-technology production facility known as Aurora Vie in Pointe-Claire, Que., on Montreal's West Island and is currently constructing an 800,000-square-foot production facility, known as Aurora Sky, at the Edmonton International Airport, and is completing a fourth facility in Lachute, Que., through its wholly owned subsidiary Aurora Larssen Projects Ltd.

We seek Safe Harbor.

© 2020 Canjex Publishing Ltd. All rights reserved.